Harrow HROW
NASDAQ HROW
$37.67 -0.18 (-0.49%)
As of: Sep 9, 2026 · 2:22 PM EDT

Harrow (HROW) Current Assets (2010 - 2026)

Harrow (HROW) posted Current Assets of $229.3 million for Q2 2026, up 1.29% on a QoQ basis from $226.4 million in Q1 2026, and up 48.05% year-over-year from $154.9 million in Q2 2025.

Analysis

Harrow (HROW) Current Assets (2010 - 2026) Analysis & Trends

Harrow has reported Current Assets for 17 years, with the latest figure at $229.3 million in Q2 2026.

  • On a quarterly basis, Current Assets rose 48.05% year-over-year to $229.3 million in Q2 2026; TTM through Jun 2026 was $229.3 million, a 48.05% increase from a year earlier, with the FY2025 full-year figure at $211.8 million, up 11.65% from the prior year.
  • Current Assets was $229.3 million for Q2 2026 at Harrow, up from $226.4 million in the prior quarter.
  • The five-year high for Current Assets was $229.3 million in Q2 2026, with the low at $51.7 million in Q1 2023.
  • Average Current Assets over 5 years is $135.7 million, with a median of $139.4 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Current Assets sank 30.78% in 2022, then soared 142.73% in 2024.
  • Over 5 years, Current Assets stood at $118.3 million in 2022, then climbed by 17.95% to $139.5 million in 2023, then soared by 35.97% to $189.7 million in 2024, then gained by 11.65% to $211.8 million in 2025, then advanced by 8.29% to $229.3 million in 2026.
  • The last three Current Assets figures came in at $229.3 million (Q2 2026), $226.4 million (Q1 2026), and $211.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 646.71 Bn 625.95 Bn 17.26 Bn 59.77 Bn
2 AbbVie 442.22 Bn 435.65 Bn 12.70 Bn 33.67 Bn
3 Merck 366.92 Bn 359.78 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 266.90 Bn 259.21 Bn 11.24 Bn 27.35 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn 41.36 Bn
6 Sanofi 52.44 Bn 45.06 Bn 10.79 Bn 36.64 Bn
7 Revolution Medicines 44.11 Bn 44.11 Bn - 4.03 Bn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 6.03 Bn
9 United Therapeutics 21.50 Bn 18.84 Bn 683.80 Mn 3.48 Bn
10 Harrow 1.41 Bn 1.32 Bn 50.36 Mn 229.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 229.31 Mn
Mar 31, 2026 226.38 Mn
Dec 31, 2025 211.75 Mn
Sep 30, 2025 177.60 Mn
Jun 30, 2025 154.89 Mn
Mar 31, 2025 169.54 Mn
Dec 31, 2024 189.65 Mn
Sep 30, 2024 147.06 Mn
Jun 30, 2024 139.39 Mn
Mar 31, 2024 125.46 Mn
Dec 31, 2023 139.48 Mn
Sep 30, 2023 110.28 Mn
Jun 30, 2023 60.30 Mn
Mar 31, 2023 51.69 Mn
Dec 31, 2022 118.26 Mn
Sep 30, 2022 64.07 Mn
Jun 30, 2022 64.70 Mn
Mar 31, 2022 62.32 Mn
Dec 31, 2021 60.66 Mn
Sep 30, 2021 91.13 Mn